danah life scienc environment unit
off-set diagnost dental weak
page full analyst note oct
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research oct
estim oct
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
uniqu busi impress histor result
compani strategi reli success manag
continu capit alloc acumen integr effort
underli
busi perform conserv use financ suggest
compani remain disciplin strategi risk
recent deal like pall nobel cepheid brought
innov industri leader higher growth opportun
expens return capit taken slide
recent year mostli like long-term outlook
major busi wed like see
evid manag wont overpay growth
follow spin-off anticip spin-off
dental segment becom major player
life scienc diagnost market continu
appreci direct manag capit deploy
life scienc
diagnost remain attract area age
popul demograph growth person medicin
demand biolog manufactur process instal
equip help maintain sticki custom base recur
see number potenti avenu manag continu
deploy capit boost competit edg diagnost
exampl gain access molecular diagnost
cepheid deal manag may want
enhanc exposur molecular genom test life
scienc side could boost chromatographi
imagin spin-off dental segment stem
segment weak perform although dental industri
exposur mostli cash pay servic combin fragment
custom base remain attract attribut market rise
corpor practic buy power increas commodit
mani product categori weaken growth profit
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
spin-off diversifi mostli
healthcare-focus instrument suppli manufactur spin
dental environment appli solut segment repres
approxim revenu respect
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
danah life scienc environment unit
off-set diagnost dental weak oct
report anoth fairli stabl quarter across
busi segment especi neg currenc
effect top bottom line intern revenu growth
oper margin improv
basi point last year put compani
track slightli outperform previou forecast
manag rais year-end adjust ep outlook
look
achiev us given perform first three
quarter year although rais fair valu
estim per share slightli increas near-
term organ growth expect combin time
valu money sinc last updat still think
danah share look modestli overvalu asid
dental segment think danah narrow moat remain
good shape especi life scienc diagnost
summar thought quarter life scienc
well environment appli segment exceed
expect off-set weaker result diagnost
dental divis life scienc segment --
organ growth basi point segment margin
expans -- post particularli strong result view
thank larg part double-digit growth bioprocess
single-us technolog among biopharma custom
legaci pall busi life scienc unit also
post high-singl digit growth suggest potenti
market share gain meanwhil doubl digit growth
water qualiti oper within environment
appli segment especi demand china led
perform divis
meanwhil diagnost divis neg
affect currenc movement weak
develop market within beckman coulter busi
quarter organ growth nearli
basis-point oper margin declin weaker
anticip manag note healthier perform
diagnost unit cepheid sustain double-
digit growth hard know chang medicar
clinic lab fee schedul might sap
demand diagnost product especi
matur clinic chemistri hematolog portion
market manag highlight weak
still think segment overal noteworthi growth
margin expans opportun ahead follow
cepheid acquisit still think manag
eventu look deploy capit genom test
portion market gain access higher growth
condit remain weak dental segment
manag continu suggest outlook improv
organ revenu fell quarter nearli
basis-point declin oper margin thank part
currenc effect invest prepar divis
expect spin-off second half still
surpris weak perform segment
support decis separ busi due
likelihood increas competit market time
includ greater buy power corpor account
buy group well rise low-pric competit
tradit consum equip remain
sore spot compani post stabl growth
specialti orthodont implant product categori
manag increas invest dental busi
target specialti segment well ramp
clear align busi specif target
stronghold area
increas fair valu estim
per share slightli rais near-term
organ growth margin forecast well cash flow
realiz sinc last updat valuat impli
price/adjust earn multipl approxim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
environment appli solut busi
alreadi post oper margin assumpt
result return invest capit gradual rise back
estim cost capit
approxim
danah diversif presenc mani stabl
industri reduc compani overal risk view
manag consist strategi creat
meaning integr overpay risk manag
abil integr pall continu turnaround nobel
oper improv cepheid profit
larg bear near-term perform exampl
forecast averag annual growth
next five year thank organ growth
growth acquisit nearli organ growth
life scienc diagnost segment offset slower
growth dental environment appli
segment expect danah abl maintain low
mid-single-digit organ growth product
segment life scienc diagnost divis
repres higher growth opportun model
small tuck-in acquisit minor contribut sale
growth acknowledg larger unpredict
deal like drive higher growth expens
capit deploy firm comfort free
forecast oper margin rise
next five year
integr pall nobel cepheid along on-going
cost save effort lead consider margin expans
life scienc diagnost dental segment
current compani lower margin divis
expect much margin improv danah
fair valu estim bull case
assum stronger organ growth help part better
macroeconom condit lead higher spend
equip dental procedur lead annual
growth organ acquisit
better-than-expect integr result deal -- particularli
pall nobel cepheid -- result oper margin near
return capit also rise midteen
scenario
next
persist weak global macroeconom condit
manag inabl spur higher growth
product develop market effort result
rel lacklust total annual growth
organ acquisit next five year
worse-than-expect integr effort addit
weak top-lin perform doesnt allow manag
effici scale oper lead modest margin
expans high-teen return capit also
bare reach bear case scenario
result fair valu estim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
maintain narrow-moat rate danah
follow spin-off includ
test measur oper fluke tektronix
root industri technolog segment
kollmorgen thomson jacob vehicl danah
remain diversifi predomin healthcare-focus
busi retain life scienc diagnost dental
water qualiti product
recur consum revenu make
benefit
predomin switch cost intang asset
also like gain modest benefit economi
scale layer adjac busi roll-up
acquisit gain consolid
improv sell distribut
purchas
effici compet
mani
commodit market howev differenti product
innov meet custom need remain
critic moat sourc view
 strategi continu focu mostli nich
oligopolist market high barrier entri creat
combin complex
instrument high switch cost extens brand
recognit nearli revenu spin-off
life scienc diagnost segment
includ legaci beckman coulter sciex leica
pall cepheid busi rel high switch
cost larg instal base equip becom
essenti compon custom workflow system
stabl instal base equip support consist
pull consum make bulk
sale divis similarli dental segment
includ implant acquir recent nobel deal
orthodont ormco directli sold specialist
demand newer innov technolog high qualiti
materi addit remain hesit switch brand
due previou train also major player
dental imag equip
although typic market leader
product categori compani remain larg
signific player industri innov
sticki relationship help preserv compani
brand number four player diagnost
exampl compet heavili roch
siemen abbott high volum clinic chemistri
immunoassay market also contend
hematolog compet sysmex anatom
patholog compet primarili roch
agil molecular diagnost asset acquir
cepheid pit compani player like roch
biomerieux second largest
dental player dentspli recent acquisit
nobel make compani one key innov
premium implant market filtrat water
busi compet compani like ge siemen
among other
think danah moat trend stabl dont forese
major disrupt technolog risk competit headwind
compani market risk increas
commodit persist area like gener dental
consum market equip offer
specialti dental product includ integr
nobel implant busi help retain overal
competit edg modest innov keep danah
competit advantag stabl manag like
continu use acquisit fill area
compani lack industri presenc recent
cepheid deal attain access molecular diagnost
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
market could also choos bolster life scienc
diagnost oper expand product breadth
build greater capabl area ga
liquid chromatographi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
post impress track record
deal enabl compani creat
competit busi boost asset
perform focu improv effici
market leadership
 strategi find busi
attract healthcar market led roic declin
year especi pursuit implant
manufactur nobel filtrat purif
odanah shift healthcar market creat less
cyclic busi attract market high
entri
plenti opportun consolid
improv perform variou fragment
nich healthcar market especi life scienc
diagnost
outstand leader
market roch siemen repres larger
potenti innov competit
osom market
exampl nobel previous suffer low
price open sourc competit lucr
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
strategi think compani maintain rel healthi
financ thank compani strong oper cash flow
combin fairli conserv use credit equiti
financ transact compani debt balanc
consider increas financ pall acquisit
follow cepheid acquisit
debt remain manag firm produc
healthi cash flow cover debt oblig pay small
dividend anticip net debt/adjust ebitda
time danah ebitda interest coverag ratio
histor remain time compani
dividend yield
danah diversif presenc mani stabl
industri reduc compani overal risk view
manag consist strategi creat
meaning integr overpay risk manag
abil integr pall continu turn around nobel
oper improv cepheid profit
larg bear near-term perform exampl
think aggress strategi creat
risk compani particularli manag begin
consist overpay asset integr effort
larg busi fail make gain materi danah
on-going shift healthcar also expos firm
market requir consist innov howev
manag stabl histori integr busi
sustain growth profit leverag
balanc sheet help keep risk
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
fidel manag research compani
share
fund
share
fund
compani high level risk compani
histor perform sharehold align
firm view although recent declin return
capit reason concern favor view
manag histor capit alloc decis
focus asset industri certain
attract characterist combin manag
abil improv oper perform
danah busi system includ lean-manufactur
japanes system continu
improv empow leadership focus
custom need combin enabl
becom major player mani attract market
materi improv mani acquir busi
impair rare compani
support view manag follow disciplin
strategi process think dental segment
manag intend spin one
area under-perform compani recent
histori manag may stuck
busi long given recent competit headwind
applaud decis separ busi
co-found brother mitchel steven rale retain
influenc compani creat
mitchel rale chairman execut committe
steven rale chairman board also
cumul approxim outstand
share thoma joyc join becam
ceo follow mani previou leadership posit
compani recent water qualiti life
scienc diagnost segment joyc also join rale
brother compani board donald ehrlich
lead independ director board sinc
begin matthew mcgrew -- lead
financ firm diagnost dental divis --
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
replac daniel coma cfo compani
transit retir director elect annual
execut compens mostli tie adjust ep
target also includ free cash flow ratio return
invest capit metric wed prefer return capit
play larger role determin compens
 heavi firm like think compani
fairli shareholder-friendli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
danah life scienc environment unit
off-set diagnost dental weak oct
report anoth fairli stabl quarter across
busi segment especi neg currenc
effect top bottom line intern revenu growth
oper margin improv
basi point last year put compani
track slightli outperform previou forecast
manag rais year-end adjust ep outlook
look
achiev us given perform first three
quarter year although rais fair valu
estim per share slightli increas near-
term organ growth expect combin time
valu money sinc last updat still think
danah share look modestli overvalu asid
dental segment think danah narrow moat remain
good shape especi life scienc diagnost
summar thought quarter life scienc
well environment appli segment exceed
expect off-set weaker result diagnost
dental divis life scienc segment --
organ growth basi point segment margin
expans -- post particularli strong result view
thank larg part double-digit growth bioprocess
single-us technolog among biopharma custom
legaci pall busi life scienc unit also
post high-singl digit growth suggest potenti
market share gain meanwhil doubl digit growth
water qualiti oper within environment
appli segment especi demand china led
perform divis
meanwhil diagnost divis neg
affect currenc movement weak
develop market within beckman coulter busi
quarter organ growth nearli
basis-point oper margin declin weaker
anticip manag note healthier perform
diagnost unit cepheid sustain double-
digit growth hard know chang medicar
clinic lab fee schedul might sap
demand diagnost product especi
matur clinic chemistri hematolog portion
market manag highlight weak
still think segment overal noteworthi growth
margin expans opportun ahead follow
cepheid acquisit still think manag
eventu look deploy capit genom test
portion market gain access higher growth
condit remain weak dental segment
manag continu suggest outlook improv
organ revenu fell quarter nearli
basis-point declin oper margin thank part
currenc effect invest prepar divis
expect spin-off second half still
surpris weak perform segment
support decis separ busi due
likelihood increas competit market time
includ greater buy power corpor account
buy group well rise low-pric competit
tradit consum equip remain
sore spot compani post stabl growth
specialti orthodont implant product categori
manag increas invest dental busi
target specialti segment well ramp
clear align busi specif target
stronghold area
remaind busi shine jul
quarter result across busi plan
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
post intern growth fall
outlook life scienc segment particular
continu benefit healthi biopharma custom
demand across number product categori -- trend
expect continu diagnost segment intern growth
fall short expect especi
manag note high-single-digit growth
cepheid expect rebound double-digit growth
howev manag highlight tough year-over-
year comparison develop market sale
slightli increas near-term project may lead
modest bump fair valu estim adjust
ep estim previous high end
manag year-end outlook fall low end
compani updat rang
implement tariff view issu rel
immateri bar potenti larger macroeconom
side-effect demand
compani biggest announc stem
decis spin-off dental segment current
repres top bottom line
respect given dental segment consist
under-perform think separ asset make
sens surpris manag choic
surmis manag realiz
attract use capit within life scienc
diagnost oper rather make necessari
invest dramat improv dental busi
busi continu fallen manag
perform goal long concern
competit issu dental industri highlight
neg moat trend rate peer like dentspli sirona
straumann addit dental segment
share mani attract razor blade attribut
busi segment posit
manag note gener consum equip
growth first time sinc segment led
larg europ china offset on-going inventori
adjust market meanwhil
specialti implant orthodont oper continu
wit low stabl growth
busi segment continu perform
well thank new product stabl underli industri
demand market share gain life scienc segment
well environment appli solut segment
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
